Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB80380 vs Entecavir Extension Study in Chronic Hepatitis B
NCT01242787Phase 2Unknown
- Sponsor
- LG Chem
- Start
- Aug 2010
- Primary completion
- Sep 2012
- Modality
- Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of besifovir dipivoxil maleate in Chronic Hepatitis B (CHB), sponsored by LG Chem. Status: unknown.
02
Drugs
besifovir dipivoxil maleate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01242787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01242787.